Gene test shows who could benefit from statins to reduce colon cancer risk: Study

A genetic test can help determine in which patients cholesterol-lowering statin drugs might have the most benefit in also reducing the risk of colorectal cancer, a new study from researchers at the University of Michigan Comprehensive Cancer Centre finds...

Read the whole article on

More from